IRIS UniCatt

Leone, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.861
EU - Europa 11.824
AS - Asia 7.171
SA - Sud America 1.330
AF - Africa 205
OC - Oceania 181
Continente sconosciuto - Info sul continente non disponibili 12
Totale 32.584
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.558
DE - Germania 5.192
SG - Singapore 2.934
CN - Cina 2.673
SE - Svezia 1.598
BR - Brasile 1.094
UA - Ucraina 1.086
IT - Italia 903
FR - Francia 620
GB - Regno Unito 611
PL - Polonia 491
IE - Irlanda 385
IN - India 317
FI - Finlandia 259
VN - Vietnam 247
ID - Indonesia 242
TR - Turchia 186
RU - Federazione Russa 185
CA - Canada 158
AU - Australia 156
AR - Argentina 97
NL - Olanda 92
MX - Messico 90
JP - Giappone 85
BD - Bangladesh 70
ES - Italia 68
IQ - Iraq 65
CI - Costa d'Avorio 51
HK - Hong Kong 51
BE - Belgio 49
ZA - Sudafrica 44
IR - Iran 32
AT - Austria 29
CH - Svizzera 29
EC - Ecuador 29
NO - Norvegia 28
VE - Venezuela 28
NZ - Nuova Zelanda 25
EG - Egitto 24
KR - Corea 24
RO - Romania 23
CO - Colombia 22
IL - Israele 22
PK - Pakistan 21
SA - Arabia Saudita 21
UZ - Uzbekistan 21
AE - Emirati Arabi Uniti 20
JO - Giordania 19
LT - Lituania 19
PY - Paraguay 19
BG - Bulgaria 18
MA - Marocco 18
KE - Kenya 17
CL - Cile 16
GR - Grecia 16
HU - Ungheria 15
DZ - Algeria 14
PT - Portogallo 14
CZ - Repubblica Ceca 13
AZ - Azerbaigian 12
SK - Slovacchia (Repubblica Slovacca) 11
CR - Costa Rica 10
KZ - Kazakistan 10
NP - Nepal 10
UY - Uruguay 10
DO - Repubblica Dominicana 9
HR - Croazia 9
JM - Giamaica 9
LV - Lettonia 9
OM - Oman 9
PE - Perù 9
GE - Georgia 8
PH - Filippine 8
TN - Tunisia 8
ET - Etiopia 7
EU - Europa 7
LB - Libano 7
MY - Malesia 7
RS - Serbia 7
TH - Thailandia 7
AL - Albania 6
BO - Bolivia 6
DK - Danimarca 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
BY - Bielorussia 5
LK - Sri Lanka 5
LU - Lussemburgo 5
MK - Macedonia 5
TW - Taiwan 5
BZ - Belize 4
GH - Ghana 4
HN - Honduras 4
KG - Kirghizistan 4
NI - Nicaragua 4
PS - Palestinian Territory 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
BB - Barbados 3
BH - Bahrain 3
Totale 32.527
Salva come PNG Salva come JPEG
Città #
Chandler 1.602
Singapore 1.344
Ashburn 1.023
Jacksonville 695
Beijing 471
Nanjing 453
San Mateo 450
Dearborn 445
Warsaw 443
Dublin 371
Ann Arbor 348
Nürnberg 329
Houston 298
Los Angeles 278
Woodbridge 278
Wilmington 256
New York 242
Jakarta 215
Milan 210
Munich 208
Seattle 206
Hangzhou 183
Hefei 182
Nanchang 181
Redwood City 153
Lawrence 149
Boston 146
Fairfield 135
Izmir 135
Bremen 130
Marseille 120
Buffalo 119
Dallas 116
Moscow 111
Kunming 100
Lancaster 98
Frankfurt am Main 97
São Paulo 92
Rome 87
Chicago 86
Cattolica 84
Shenyang 80
Hanoi 79
Zhengzhou 74
Ho Chi Minh City 73
University Park 67
Tianjin 66
Guangzhou 62
Hebei 61
Leawood 59
Princeton 58
Mountain View 55
Boardman 52
London 52
Abidjan 51
Redmond 51
Changsha 50
Tokyo 49
Hong Kong 48
Auburn Hills 46
Jiaxing 46
Norwalk 46
Cambridge 44
Shanghai 44
Brussels 43
Philadelphia 43
Toronto 40
Brooklyn 39
Kent 39
Pune 39
San Francisco 39
Santa Clara 38
Sydney 37
Jinan 35
Fremont 34
Atlanta 33
Düsseldorf 32
Helsinki 32
Phoenix 32
Augusta 31
Orem 29
Rio de Janeiro 28
Belo Horizonte 27
Denver 27
Detroit 27
Melbourne 27
San Jose 27
Baghdad 26
Portland 26
San Diego 25
Amsterdam 24
Johannesburg 23
Porto Alegre 23
Simi Valley 23
Adelaide 22
Brisbane 22
Lanzhou 22
Stockholm 22
Changchun 21
Montreal 21
Totale 15.060
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 2.901
Incidence of acute myeloid leukemia after breast cancer 363
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 340
Factors associated with mortality in bacteremic patients with haematologic malignancies 337
Fanconi anemia gene variants in therapy-related myeloid neoplasms 303
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 274
THE PROGNOSTIC ROLE OF EBV IN PERIPHERAL BLOOD OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA 272
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 260
Therapy-related leukemias and myelodysplasia : susceptibility and incidence. 256
Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old woman 247
A Novel Route of Transplantation of Human Cord Blood Stem Cells in Preimmune Fetal Sheep: The Intracelomic Cavity 246
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 243
A) A human umbilical cord stem cell rescue therapy in a murine model of toxic liver injury. 221
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 216
Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity. 215
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 215
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 215
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 211
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 209
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 205
-Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity 202
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 202
Systemic granulomatous reaction secondary to treatment of bladder cancer with Bacillus Calmette-Guerin 201
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 199
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin 198
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 195
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 194
Von hippel-lindau disease and erythrocytosis 192
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. 187
Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic Scoring System: validation by the Gruppo Romano Mielodisplasie Italian Regional Database 186
Correlation between paraproteinaemia and viral reactivation after allo-SCT 185
in Higher-Risk Myelodysplastic Syndromes and Low Blast Count Acute Myeloid Leukemia: Results of the BMT-AZA Prospective Study 184
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluation 180
Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness 178
Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats. 177
The intracoelomic route: a new approach for in utero human cord blood stem cell transplantation. 177
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 176
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 175
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 174
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 173
Why methylation is not a marker predictive of response to hypomethylating agents 173
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 171
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 170
Characterization of anti-D monoclonal antibody reagents based on their reactivity with the weak D phenotype 169
-No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure 169
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 169
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 168
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 167
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 166
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 166
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. 164
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 164
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 163
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 163
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 163
-How does human stem cell therapy influence gene expression after liver injury? Microarray evaluation on a rat model 162
-Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats 162
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 162
T lymphocyte subsets and platelet-associated IgG in idiopathic thrombocytopenic purpura: effect of splenectomy. 161
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 161
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 161
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms. 161
In vitro cardiomyocyte differentiation of umbilical cord blood cells: crucial role for c-kit(+) cells 161
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 160
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 159
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 159
Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome 158
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 158
Epigenetic changes in therapy-related MDS/AML 157
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 157
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 156
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 156
Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study). 156
A human umbilical cord stem cell rescue therapy in a murine model of toxic liver injury. 154
Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect 154
Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function 153
Similarities and differences between therapy-related and elderly acute myeloid leukemia 152
Gene profiling of bone marrow- and adipose tissue-derived stromal cells: a key role of Kruppel-like factor 4 in cell fate regulation 152
New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia 151
Non-invasive detection of fetal Rhesus D Status: A comparison between Polymerase Chain Reaction and flow Cytometry 151
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 151
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: Safety and efficacy evaluation. 151
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 149
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments 148
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 148
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 148
The use of low-dose alemtuzumab in pretreated B-cell chronic lymphocytic leukemia. Leukemia. 147
Primary plasma cell leukemia followed by testicular plasmacytoma 146
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 146
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 146
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 145
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma 144
Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 144
All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients 144
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 143
Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis 142
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas 141
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 141
Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto SCTsuccessfully treated with combination treatment. 140
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 140
Totale 20.827
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.673
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.673
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.637 0 0 0 0 0 213 324 58 285 162 529 66
2021/20222.089 219 244 35 105 138 77 54 347 86 137 283 364
2022/20234.360 520 639 331 722 311 530 223 346 508 46 118 66
2023/20242.556 104 569 88 110 149 386 124 104 102 179 356 285
2024/20254.327 322 248 396 178 442 120 147 211 674 338 666 585
2025/20265.360 1.460 329 549 876 1.672 474 0 0 0 0 0 0
Totale 32.717